INTERNATIONAL PATENT: HBC IMMUNOLOGY INC. FILES APPLICATION FOR "LIPOPEPTIDE COMPOUNDS AND USE IN MODULATING EOSINOPHILIA"

GENEVA, May 19 -- HBC IMMUNOLOGY INC. (1455 Adams Drive, Suite 2043Menlo Park, California 94025) filed a patent application (PCT/US2024/054584) for "LIPOPEPTIDE COMPOUNDS, AND USE IN MODULATING EOSINOPHILIA" on Nov 05, 2024. With publication no. WO/2025/101524, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRAMROZE, Bomi Patel (c/o HBC Immunology Inc.1455 Adams Drive, Suite 2043Menlo Park, California 94025), CURRIE, Crawford Linden Alexander (c/o HBC Immunology Inc.1455 Adams Drive, Suite 2043Menlo Park, California 9402...